Complex aneuploidy triggers autophagy and p53-mediated apoptosis and impairs the second lineage segregation in human preimplantation embryos

  1. Marius Regin
  2. Yingnan Lei
  3. Edouard Couvreu De Deckersberg
  4. Charlotte Janssens
  5. Anfien Huyghebaert
  6. Yves Guns
  7. Pieter Verdyck
  8. Greta Verheyen
  9. Hilde Van de Velde
  10. Karen Sermon
  11. Claudia Spits  Is a corresponding author
  1. Brussels Health Campus/Faculty of Medicine and Pharmacy, Research Group Genetics Reproduction and Development, Vrije Universiteit Brussel, Belgium
  2. Brussels Health Campus, Brussels IVF, Universitair Ziekenhuis Brussel (UZ Brussel), Belgium
  3. Brussels Health Campus, Medical Genetics, Universitair Ziekenhuis Brussel (UZ Brussel), Belgium
7 figures, 1 table and 10 additional files

Figures

Figure 1 with 1 supplement
RNA-sequencing of trophectoderm cells reveals gene dosage defects and transcriptomic signatures of p53 activation and apoptosis.

(a) Principal component analysis after transcriptome analysis of aneuploid versus euploid embryos. T=Trisomy, M=Monosomy. (b) Comparison between the diagnosis of aneuploid embryos obtained after …

Figure 1—figure supplement 1
Expanded RNA-sequencing analysis.

(a) Principal component analysis of reversine versus euploid embryos. (b) InferCNV analysis of individual euploid samples compared to the reference set. (c) InferCNV analysis of individual reversine …

Human embryos with the highest number of genes with abnormal copy number show stronger p53 pathway and apoptosis response.

(a) Principal component analysis after transcriptome analysis of high-dosage aneuploid versus euploid embryos. T=Trisomy, M=Monosomy. (b) Volcano plot after differential gene expression analysis …

Figure 3 with 1 supplement
Immunostaining reveals increased proteotoxic stress, DNA-damage independent p53-activation, autophagy, and apoptosis.

(a) Orthogonal projections after immunostaining of euploid and aneuploid embryos for DNA (white) and CASP3/7 (green). T=Trisomy, M=Monosomy. Source: Experiment 1. (b) Orthogonal projections after …

Figure 3—figure supplement 1
S15-p53 expression in trophectoderm (TE) vs OCT4-positive cells (inner cell mass, ICM/epiblast, EPI) in aneuploid embryos.

(a) Orthogonal projections after immunostaining of euploid and aneuploid embryos for DNA (white), S15p53 (turquoise), and OCT4 (magenta). (b) Percentages of nuclei positive for S15p53 per embryo in …

Aneuploid human embryos show less cells in trophectoderm and OCT4-positive cells and impaired lineage segregation events.

(a) Orthogonal projections after immunostaining of euploid (n=7) and aneuploid embryos (n=10) for DNA (white) and NANOG (green). T=Trisomy. Source: Experiment 3. (b) NANOG nuclear enrichment in …

Author response image 1
Author response image 2
Author response image 3

Tables

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
AntibodyAnti-HSP70 (Mouse monoclonal)InvitrogenMA3-007IF(1:200)
AntibodyAnti-SQSTM1/p62
(Mouse monoclonal)
Abcamab56416IF(1:100)
AntibodyRecombinant Anti-LC3B (Rabbit monoclonal)Abcamab192890IF(1:838)
AntibodyAnti-OCT3/4 (Mouse monoclonal)Santa-Cruzsc-5279IF(1:200)
AntibodyAnti-human phosphor-p53 S15 (Rabbit polyclonal)R&DAF1043IF(1:100)
AntibodyAnti-GATA4 (Rat monoclonal)Invitrogen14-9980-82IF(1:400)
AntibodyAnti-DRAM (Rabbit polyclonal)InvitrogenPA20-335IF(1:500)
AntibodyAnti-phospho-histone H2A.X Ser139 (Mouse monoclonal)Sigma-Aldrich05–636IF(1:500)
AntibodyAnti-NANOG (Goat polyclonal)R&DAF1197IF(1:200)
Chemical compound, drug ReversineStem Cell Technologies# 72614 0.5 µM
OtherCaspGLOW Fluorescein Active Caspase-8 Staining KitInvitrogen88-7005-42IF(1:300)
OtherCellEvent Caspase-3/7 Green Detection ReagentInvitrogenC10423IF(1:400)

Additional files

MDAR checklist
https://cdn.elifesciences.org/articles/88916/elife-88916-mdarchecklist1-v1.docx
Supplementary file 1

PGT diagnoses and inferCNV results first experiment.

https://cdn.elifesciences.org/articles/88916/elife-88916-supp1-v1.xlsx
Supplementary file 2

Differentially expressed genes aneuploid versus euploid embryos.

https://cdn.elifesciences.org/articles/88916/elife-88916-supp2-v1.xlsx
Supplementary file 3

Differentially expressed genes reversine versus euploid embryos.

https://cdn.elifesciences.org/articles/88916/elife-88916-supp3-v1.xlsx
Supplementary file 4

Ranks of imbalanced gene loci for the first experiment.

https://cdn.elifesciences.org/articles/88916/elife-88916-supp4-v1.xlsx
Supplementary file 5

Differentially expressed genes high-dosage versus euploid embryos.

https://cdn.elifesciences.org/articles/88916/elife-88916-supp5-v1.xlsx
Supplementary file 6

Gene dosage ranking Experiment 3 and 4.

https://cdn.elifesciences.org/articles/88916/elife-88916-supp6-v1.xlsx
Supplementary file 7

PGT diagnoses experiment 4.

https://cdn.elifesciences.org/articles/88916/elife-88916-supp7-v1.xlsx
Supplementary file 8

Gene dosage classification experiment 4.

https://cdn.elifesciences.org/articles/88916/elife-88916-supp8-v1.xlsx
Supplementary file 9

Antibodies and reagents used in this study.

https://cdn.elifesciences.org/articles/88916/elife-88916-supp9-v1.xlsx

Download links